USPTO serial 97679967
ELEVIAN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- RINGLE, JAMES W
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ELEVIAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Miami Beach, FL
Miami Beach, FL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John L. Slafsky
John L. Slafsky WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for the treatment and prevention of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and disease and conditions associated with aging and diabetes; transdermal drug delivery patches sold with pharmaceutical preparations for the treatment of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and diseases and conditions associated with aging and diabetes; implantable subcutaneous or intramuscular drug delivery devices sold with pharmaceutical preparations for the treatment of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and diseases and conditions associated with aging and diabetes; medical devices, namely, implantable or external pumps sold with pharmaceutical preparations for the treatment of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and disease and conditions associated with aging and diabetes for delivering drugs | ACTIVE | — |
| 010 | drug delivery systems; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; vacuum pumps for medical purposes; tubing for use with catheters; drug eluting coatings sold as an integral part of catheters | ACTIVE | — |
| 044 | pharmaceutical and medical diagnostic consultation services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Elevian, Inc.
- Other trademarks owned by Elevian, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named ELEVIAN
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 1, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 11, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 11, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 11, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 12, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 17, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 17, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 13, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 13, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 13, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 13, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 13, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 29, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 7, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 19, 2022 | NWAP | NEW APPLICATION ENTERED | — |